Maintenance. We are currently updating the site. Please check back shortly
Members login
  • TrustLaw
  • Members Portal
Subscribe

Ameridose agrees to extend shutdown amid meningitis probe

Source: Thomson Reuters Foundation - Fri, 19 Oct 2012 05:53 PM
Author: Reuters
hum-dis
Tweet Recommend Google + LinkedIn Bookmark Email Print
Leave us a comment

BOSTON, Oct 19 (Reuters) - Ameridose LLC, sister company to the New England Compounding Center at the heart of the U.S. meningitis outbreak, said on Friday it has agreed to extend a temporary shutdown while state and federal regulators continue an investigation into the company.

Ameridose, based in Westborough, Massachusetts, shares some common ownership with NECC, which is why investigators began an inspection of the company on Oct. 10.

Ameridose said it has agreed to the extended shutdown "in the spirit of full cooperation" and cited an agreement with the Massachusetts Board of Registration in Pharmacy which states that neither the board nor the company is "aware that any product compounded or produced" by Ameridose is in any way unfit for use or consumption.

The company did not say how long the extension will last. (Reporting By Toni Clarke; Editing by Gerald E. McCormick)

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of the Thomson Reuters Foundation. For more information see our Acceptable Use Policy.

comments powered by Disqus
TOPICAL CONTENT
Topical content
LATEST SLIDESHOW

Latest slideshow

See allSee all
FEATURED JOBS
Featured jobs